866-997-4948(US-Canada Toll Free)

United States Viral Vaccines Market Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 116 Pages

Notes:
Sales, means the sales volume of Viral Vaccines
Revenue, means the sales value of Viral Vaccines

This report studies sales (consumption) of Viral Vaccines in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Attenuated Vaccine
Inactivated Vaccine
Split by applications, this report focuses on sales, market share and growth rate of Viral Vaccines in each application, can be divided into
Hospital
Pharmaceutical Factory
Research Institute
Other

Table of Contents

United States Viral Vaccines Market Report 2017
1 Viral Vaccines Overview
1.1 Product Overview and Scope of Viral Vaccines
1.2 Classification of Viral Vaccines
1.2.1 Attenuated Vaccine
1.2.2 Inactivated Vaccine
1.3 Application of Viral Vaccines
1.3.1 Hospital
1.3.2 Pharmaceutical Factory
1.3.3 Research Institute
1.3.4 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Viral Vaccines (2012-2022)
1.4.1 United States Viral Vaccines Sales and Growth Rate (2012-2022)
1.4.2 United States Viral Vaccines Revenue and Growth Rate (2012-2022)

2 United States Viral Vaccines Competition by Manufacturers
2.1 United States Viral Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Viral Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Viral Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Viral Vaccines Market Competitive Situation and Trends
2.4.1 Viral Vaccines Market Concentration Rate
2.4.2 Viral Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Viral Vaccines Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Viral Vaccines Sales and Market Share by States (2012-2017)
3.2 United States Viral Vaccines Revenue and Market Share by States (2012-2017)
3.3 United States Viral Vaccines Price by States (2012-2017)

4 United States Viral Vaccines Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Viral Vaccines Sales and Market Share by Type (2012-2017)
4.2 United States Viral Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Viral Vaccines Price by Type (2012-2017)
4.4 United States Viral Vaccines Sales Growth Rate by Type (2012-2017)

5 United States Viral Vaccines Sales (Volume) by Application (2012-2017)
5.1 United States Viral Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Viral Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Viral Vaccines Manufacturers Profiles/Analysis
6.1 GSK
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Viral Vaccines Product Type, Application and Specification
6.1.2.1 Attenuated Vaccine
6.1.2.2 Inactivated Vaccine
6.1.3 GSK Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.2 Viral Vaccines Product Type, Application and Specification
6.2.2.1 Attenuated Vaccine
6.2.2.2 Inactivated Vaccine
6.2.3 Merck Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Novartis
6.3.2 Viral Vaccines Product Type, Application and Specification
6.3.2.1 Attenuated Vaccine
6.3.2.2 Inactivated Vaccine
6.3.3 Novartis Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Viral Vaccines Product Type, Application and Specification
6.4.2.1 Attenuated Vaccine
6.4.2.2 Inactivated Vaccine
6.4.3 Pfizer Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Sanofi
6.5.2 Viral Vaccines Product Type, Application and Specification
6.5.2.1 Attenuated Vaccine
6.5.2.2 Inactivated Vaccine
6.5.3 Sanofi Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bayer
6.6.2 Viral Vaccines Product Type, Application and Specification
6.6.2.1 Attenuated Vaccine
6.6.2.2 Inactivated Vaccine
6.6.3 Bayer Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Zoetis
6.7.2 Viral Vaccines Product Type, Application and Specification
6.7.2.1 Attenuated Vaccine
6.7.2.2 Inactivated Vaccine
6.7.3 Zoetis Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 AstraZeneca
6.8.2 Viral Vaccines Product Type, Application and Specification
6.8.2.1 Attenuated Vaccine
6.8.2.2 Inactivated Vaccine
6.8.3 AstraZeneca Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Johnson
6.9.2 Viral Vaccines Product Type, Application and Specification
6.9.2.1 Attenuated Vaccine
6.9.2.2 Inactivated Vaccine
6.9.3 Johnson Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 CSL
6.10.2 Viral Vaccines Product Type, Application and Specification
6.10.2.1 Attenuated Vaccine
6.10.2.2 Inactivated Vaccine
6.10.3 CSL Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Viral Vaccines Manufacturing Cost Analysis
7.1 Viral Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Viral Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Viral Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Viral Vaccines Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Viral Vaccines Market Forecast (2017-2022)
11.1 United States Viral Vaccines Sales, Revenue Forecast (2017-2022)
11.2 United States Viral Vaccines Sales Forecast by Type (2017-2022)
11.3 United States Viral Vaccines Sales Forecast by Application (2017-2022)
11.4 Viral Vaccines Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Viral Vaccines
Table Classification of Viral Vaccines
Figure United States Sales Market Share of Viral Vaccines by Type in 2015
Figure Attenuated Vaccine Picture
Figure Inactivated Vaccine Picture
Table Application of Viral Vaccines
Figure United States Sales Market Share of Viral Vaccines by Application in 2015
Figure Hospital Examples
Figure Pharmaceutical Factory Examples
Figure Research Institute Examples
Figure Other Examples
Figure United States Viral Vaccines Sales and Growth Rate (2012-2022)
Figure United States Viral Vaccines Revenue and Growth Rate (2012-2022)
Table United States Viral Vaccines Sales of Key Manufacturers (2015 and 2016)
Table United States Viral Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Viral Vaccines Sales Share by Manufacturers
Figure 2016 Viral Vaccines Sales Share by Manufacturers
Table United States Viral Vaccines Revenue by Manufacturers (2015 and 2016)
Table United States Viral Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Viral Vaccines Revenue Share by Manufacturers
Table 2016 United States Viral Vaccines Revenue Share by Manufacturers
Table United States Market Viral Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Viral Vaccines Average Price of Key Manufacturers in 2015
Figure Viral Vaccines Market Share of Top 3 Manufacturers
Figure Viral Vaccines Market Share of Top 5 Manufacturers
Table United States Viral Vaccines Sales by States (2012-2017)
Table United States Viral Vaccines Sales Share by States (2012-2017)
Figure United States Viral Vaccines Sales Market Share by States in 2015
Table United States Viral Vaccines Revenue and Market Share by States (2012-2017)
Table United States Viral Vaccines Revenue Share by States (2012-2017)
Figure Revenue Market Share of Viral Vaccines by States (2012-2017)
Table United States Viral Vaccines Price by States (2012-2017)
Table United States Viral Vaccines Sales by Type (2012-2017)
Table United States Viral Vaccines Sales Share by Type (2012-2017)
Figure United States Viral Vaccines Sales Market Share by Type in 2015
Table United States Viral Vaccines Revenue and Market Share by Type (2012-2017)
Table United States Viral Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Viral Vaccines by Type (2012-2017)
Table United States Viral Vaccines Price by Type (2012-2017)
Figure United States Viral Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Viral Vaccines Sales by Application (2012-2017)
Table United States Viral Vaccines Sales Market Share by Application (2012-2017)
Figure United States Viral Vaccines Sales Market Share by Application in 2015
Table United States Viral Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Viral Vaccines Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Viral Vaccines Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Viral Vaccines Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Viral Vaccines Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Viral Vaccines Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Viral Vaccines Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Viral Vaccines Sales Market Share (2012-2017)
Table Zoetis Basic Information List
Table Zoetis Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Zoetis Viral Vaccines Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Viral Vaccines Sales Market Share (2012-2017)
Table Johnson Basic Information List
Table Johnson Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson Viral Vaccines Sales Market Share (2012-2017)
Table CSL Basic Information List
Table CSL Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table CSL Viral Vaccines Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral Vaccines
Figure Manufacturing Process Analysis of Viral Vaccines
Figure Viral Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Viral Vaccines Major Manufacturers in 2015
Table Major Buyers of Viral Vaccines
Table Distributors/Traders List
Figure United States Viral Vaccines Production and Growth Rate Forecast (2017-2022)
Figure United States Viral Vaccines Revenue and Growth Rate Forecast (2017-2022)
Table United States Viral Vaccines Production Forecast by Type (2017-2022)
Table United States Viral Vaccines Consumption Forecast by Application (2017-2022)
Table United States Viral Vaccines Sales Forecast by States (2017-2022)
Table United States Viral Vaccines Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *